Victory Capital Management
BHVN icon

Victory Capital Management’s Biohaven BHVN Stock Holding History

Victory Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Buy
14,578
+2,129
+17% +$23.3K ﹤0.01% 2255
2025
Q4 		$141K Sell
12,449
-3,821
-23% -$47.3K ﹤0.01% 2243
2025
Q3 		$244K Sell
16,270
-44,752
-73% -$651K ﹤0.01% 2185
2025
Q2 		$861K Sell
61,022
-207,492
-77% -$3.7M ﹤0.01% 1906
2025
Q1 		$6.46M Sell
268,514
-89,251
-25% -$3.15M 0.01% 1202
2024
Q4 		$13.4M Sell
357,765
-5,850
-2% -$273K 0.01% 984
2024
Q3 		$18.2M Buy
363,615
+145,960
+67% +$5.68M 0.02% 883
2024
Q2 		$7.55M Buy
217,655
+8,217
+4% +$325K 0.01% 1161
2024
Q1 		$11.5M Buy
209,438
+50,925
+32% +$2.52M 0.01% 1026
2023
Q4 		$6.78M Buy
+158,513
New +$4.93M 0.01% 1177
2023
Q2 		– Sell
-60,440
Closed -$826K – 2525
2023
Q1 		$826K Buy
+60,440
New +$962K ﹤0.01% 1793

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's BHVN Position: Q1 2026 in Review

Victory Capital Management increased its Biohaven (BHVN) stake by 17% in Q1 2026, buying an estimated $23.3K and bringing the position to 14,578 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Victory Capital Management first reported a position in BHVN in Q1 2023 and has held it in 11 quarters since. The position peaked at $18.2M in Q3 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Victory Capital Management held 14,578 shares of Biohaven worth $123K as of Q1 2026.
  • Victory Capital Management bought 2,129 Biohaven shares in Q1 2026, an estimated $23.3K.
  • Biohaven made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2255 holding.
  • Victory Capital Management first reported a position in Biohaven in Q1 2023 and has held it in 11 quarters since.
  • Victory Capital Management's Biohaven position peaked at $18.2M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.